Chemical Compound

7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide-d7; 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone-d7; Diulo-d7; Metenix-d7; Metozalone-d7; Mykrox-d7; Normelan-d7; Oldren-d7; SR 720-22-d7; Xuret-d7; Zaroxolyn-d7;

CAS Registry Number 17560-51-9
返回搜索 申请报价
7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide-d7; 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone-d7; Diulo-d7; Metenix-d7; Metozalone-d7; Mykrox-d7; Normelan-d7; Oldren-d7; SR 720-22-d7; Xuret-d7; Zaroxolyn-d7; 结构式
Primary record

7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide-d7; 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone-d7; Diulo-d7; Metenix-d7; Metozalone-d7; Mykrox-d7; Normelan-d7; Oldren-d7; SR 720-22-d7; Xuret-d7; Zaroxolyn-d7;

库存
2,053 克
纯度
98.1 %
CAS
17560-51-9

化合物标识与属性

CAS
17560-51-9
PubChem CID
4170
SMILES
CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
Canonical SMILES
Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C

名称与同义词

  • metolazone
  • Zaroxolyn
  • Diulo
  • Mykrox
  • Oldren
  • Metenix
  • Metalozone
  • Microx
  • Metolazona
  • Metolazonum
  • 17560-51-9
  • metozalone
  • Normelan
  • Xuret
  • Metalazone
  • Metazoline
  • Metolazonum [INN-Latin]
  • Metolazona [INN-Spanish]
  • Metolazone (Zaroxolyn)
  • Zaroxolyn (TN)
  • Metolazone CRS
  • Metolazone-d7
  • Metolazone, (+)-
  • Metolazone, (-)-
  • C16H16ClN3O3S
  • Prestwick_333
  • Metolazone[diuretic]
  • Mykrox (TN)
  • metolazone (product)
  • Metolazone(Zaroxolyn)
  • Metolazone (Standard)
  • Metolazone(Zaroxolyn)/
  • TZ7V40X7VX
  • Spectrum_000456
  • SR 720-22
  • METOLAZONE [MI]
  • RefChem:58440
  • UNII-TZ7V40X7VX
  • DTXSID6045167
  • SR-720-22
  • AC1L1HKJ
  • METOLAZONE [INN]
  • METOLAZONE [JAN]
  • Prestwick0_000112
  • Prestwick1_000112
  • Prestwick2_000112
  • Prestwick3_000112
  • Spectrum2_001741
  • Spectrum4_000229
  • Spectrum5_001237
  • METOLAZONE [HSDB]
  • METOLAZONE [USAN]
  • NM7V2Y3G0U
  • AQCHWTWZEMGIFD-UHFFFAOYSA-N
  • Metolazone (JAN/USP/INN)
  • METOLAZONE [VANDF]
  • CHEMBL878
  • D01WLC
  • UNII-NM7V2Y3G0U
  • HSDB 3367
  • METOLAZONE [MART.]
  • Metolazone[hypotensive drug]
  • (non-labelled)Metolazone-d7
  • METOLAZONE [USP-RS]
  • METOLAZONE [WHO-DD]
  • Metolazone [USAN:BAN:INN:JAN]
  • SCHEMBL40558
  • BSPBio_000124
  • BSPBio_002422
  • DTXCID4025167
  • KBioGR_000897
  • KBioSS_000936
  • CHEBI:64354
  • MLS002153316
  • MLS002154200
  • orb134400
  • DivK1c_000275
  • NSC-759581
  • SPECTRUM2300325
  • 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
  • EINECS 241-539-3
  • SPBio_001842
  • SPBio_002063
  • MFCD00069304
  • BPBio1_000138
  • GTPL4838
  • orb2815831
  • METOLAZONE [EP IMPURITY]
  • METOLAZONE [ORANGE BOOK]
  • Mykrox;Zaroxolyn;Diulo;Zaroxolyn
  • SCHEMBL29382896
  • UNII-NN9U607695
  • BDBM25899
  • CTK8B4741
  • ERK5-2O16
  • HMS500N17
  • HY-B0209R
  • KBio1_000275
  • KBio2_000936
  • KBio2_003504
  • KBio2_006072
  • KS-00000ZJQ
  • SR72022
  • 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-
  • 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
  • BRN 0965506
  • C03BA08
  • CID4170
  • METOLAZONE [EP MONOGRAPH]
  • NINDS_000275
  • BCPP000166
  • GLXC-05373
  • HMS1568G06
  • HMS1922L16
  • HMS2093P14
  • HMS2095G06
  • HMS2230J15
  • HMS3261J22
  • HMS3373C11
  • HMS3655M09
  • HMS3712G06
  • HMS3744I19
  • HMS5079C20
  • METOLAZONE [USP MONOGRAPH]
  • Pharmakon1600-02300325
  • Metolazone [USAN:INN:BAN:JAN]
  • NN9U607695
  • BCP21574
  • CID:4170
  • EBD54305
  • HY-B0209
  • Metolazone [USAN:USP:INN:BAN:JAN]
  • MSK10506
  • C16-H16-Cl-N3-O3-S
  • Tox21_110186
  • Tox21_113526
  • Tox21_500610
  • 2-BROMO-5-NITRONICOTINICACID
  • ABP000634
  • ANW-46001
  • CCG-39450
  • EBC-11132
  • NCGC00093985-07
  • NSC759581
  • s1610
  • Metolazone for system suitability CRS
  • Mykrox, Zaroxolyn, Diulo, Metolazone
  • AKOS015897109
  • Metolazone, >=98% (HPLC), solid
  • Tox21_110186_1
  • 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide
  • BCP9000920
  • CS-2150
  • DB00524
  • FM25978
  • J3.450I
  • KS-5139
  • LP00610
  • NSC 759581
  • SDCCGSBI-0051460.P003
  • SR 720 22
  • IDI1_000275
  • 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone
  • NCGC00015630-02
  • NCGC00093985-01
  • NCGC00093985-02
  • NCGC00093985-03
  • NCGC00093985-04
  • NCGC00093985-05
  • NCGC00093985-06
  • NCGC00093985-08
  • NCGC00093985-10
  • NCGC00093985-11
  • NCGC00093985-20
  • NCGC00261295-01
  • 4CA-0814
  • AN-11710
  • AS-13016
  • H024
  • SMR001230730
  • 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
  • SBI-0051460.P002
  • SID:134222276
  • 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chlor
  • 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
  • AB0012835
  • AB2000160
  • CAS-17560-51-9
  • DB-044227
  • LS-140226
  • TC-134746
  • AB00052055
  • NS00004329
  • ST24029920
  • SW196612-3
  • 5-25-09-00212 (Beilstein Handbook Reference)
  • D00431
  • AB00052055-08
  • AB00052055_09
  • AB00052055_10
  • 560M519
  • A812099
  • D008788
  • EN300-23818025
  • SR-05000001765
  • 6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-7-chloro-2-methyl-4-oxo-3-o-tolyl-
  • 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-
  • Q1169561
  • SR-05000001765-1
  • SR-05000001765-4
  • SR-05000001765-7
  • BRD-A61793559-001-05-7
  • BRD-A61793559-001-08-1
  • BRD-A61793559-001-14-9
  • BRD-A61793559-001-15-6
  • BRD-A61793559-001-16-4
  • Metolazone, European Pharmacopoeia (EP) Reference Standard
  • 56436-32-9
  • 7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide
  • Metolazone, United States Pharmacopeia (USP) Reference Standard
  • 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro- 2-methyl-3-(2-methylphenyl)-4-oxo-
  • 56436-31-8
  • 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (+)-
  • 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-, (-)-
  • 7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydro-6-quinazolinesulfonamide #
  • 7-Chloro-2-methyl-4-oxo-3-(o-tolyl)-1,2,3,4-tetrahydroquizoline-6-sulfomide
  • 7-chloro-2-methyl-4-oxo-3-o-tolyl-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
  • Metolazone for system suitability, European Pharmacopoeia (EP) Reference Standard
  • 241-539-3
  • 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide-d7; 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone-d7; Diulo-d7; Metenix-d7; Metozalone-d7; Mykrox-d7; Normelan-d7; Oldren-d7; SR 720-22-d7; Xuret-d7; Zaroxolyn-d7;
  • Metolazone; (2RS)-7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide